(Q34619209)

3 August 2017

1 reference

title

Naltrexone in the treatment of heroin dependence: relationship with depression and risk of overdose (English)

1 reference

3 August 2017

0 references

1 reference

1

Alison J Ritter

1 reference

3 August 2017

publication date

1 April 2002

1 reference

Australian and New Zealand Journal of Psychiatry

3 August 2017

published in

1 reference

3 August 2017

volume

36

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

224-228

1 reference

Naltrexone treatment of heroin addiction: efficacy and safety in a double-blind dosage comparison

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01012.X

Polydrug dependence and psychiatric comorbidity among heroin injectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01012.X

Aversive effects of naltrexone in subjects not dependent on opiates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01012.X

Effects of naltrexone on mood and neuroendocrine function in normal adult males

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01012.X

Naltrexone-induced dysphoria in former opioid addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01012.X

The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study. The Naltrexone Usage Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01012.X

Naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01012.X

The efficacy of naltrexone in preventing reabuse of heroin after detoxification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01012.X

Follow-up after a six-month maintenance period on naltrexone versus placebo in heroin addicts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01012.X

Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01012.X

Aftercare on Narcotic Antagonists: Prospects and Problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01012.X

Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01012.X

Chronic naloxone results in prolonged increases in opiate binding sites in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01012.X

Naltrexone Maintenance: Effect on Morphine Sensitivity in Normal Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01012.X

Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1614.2002.01012.X

10.1046/J.1440-1614.2002.01012.X

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference